Inactief instrument

Andere talen Egalet Corp Nasdaq

Aandelen

US28226B1044

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

ZYLA LIFE SCIENCES : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-05-20
ZYLA LIFE SCIENCES : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements (form 8-K)	20-05-20
Zyla Life Sciences Repaid All Outstanding Indebtedness and Terminated the Commitment Under its Revolving Credit Agreement	20-05-20
Assertio and Zyla Life Sciences Announces Board Appointments to Combined Company	20-05-20
Assertio Therapeutics, Inc. completed the acquisition of Zyla Life Sciences.	20-05-20
ZYLA LIFE SCIENCES : Other Events, Financial Statements and Exhibits (form 8-K)	15-05-20
ZYLA LIFE SCIENCES : Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)	15-05-20
ZYLA LIFE SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	14-05-20
Zyla Life Sciences Reports Earnings Results for the First Quarter Ended March 31, 2020	14-05-20
Zyla Life Sciences : to Host Conference Call and Webcast to Discuss First Quarter 2020 Financial Results on May 15, 2020	01-05-20
Zyla Life Sciences : Assertio Therapeutics Announces its Virtual 2020 Annual Meeting on May 19, 2020, and Mailing of its Joint Proxy Statement/Prospectus	20-04-20
ZYLA LIFE SCIENCES : Change in Directors or Principal Officers, Other Events (form 8-K)	13-04-20
ZYLA LIFE SCIENCES : Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)	27-03-20
ZYLA LIFE SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	26-03-20
Zyla Life Sciences Reports Earnings Results for the Full Year Ended December 31, 2019	26-03-20
Zyla Life Sciences Auditor Raises 'Going Concern' Doubt	26-03-20
Zyla Life Sciences and Assertio Therapeutics Announce Management Appointments	17-03-20
Assertio Therapeutics, Inc. entered into an agreement to acquire Zyla Life Sciences for $20.9 million.	16-03-20
Zyla Life Sciences : to Host Conference Call and Webcast to Discuss Year End 2019 Financial Results on March 27, 2020	13-03-20
ZYLA LIFE SCIENCES : Entry into a Material Definitive Agreement, Other Events (form 8-K)	28-01-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Egalet Corp Nasdaq

Aandelen

US28226B1044

Andere talen

Filters